CAC 40 Rallies As Industrial Output Rebounds
(RTTNews) - French stocks were trading higher on Friday after official data showed France's industrial production rebounded in April, led by a sharp recovery in petroleum output.
Industrial output logged a monthly growth of 0.8 percent, reversing the 1.1 percent decrease in March. Production was expected to climb 0.3 percent.
The passing of the U.S. debt ceiling bill and optimism that the U.S. Federal Reserve will pause interest-rate hikes in June also buoyed investor sentiment.
The benchmark CAC 40 was up 64 points, or 0.9 percent, at 7,199 after gaining 0.6 percent the previous day.
The dollar extended slide while Treasury yields held steady ahead of the all-important U.S. jobs data due later in the day.
read more
Cummins And Isuzu Motors Launch New 6.7-Liter Engine For Japan, Southeast Asia And Other Markets
Cummins Inc. (CMI) and truck manufacturer Isuzu Motors Ltd. announced Monday the launch of a new 6.7-liter engine jointly developed by the two companies, designed for use in Isuzu's new medium-duty truck lineup.
RTTNews
|
4h 2min ago
Axalta Coating To Acquire CoverFlexx Group For $285 Mln Plus Potential $10 Mln Earnout
Coatings company Axalta Coating Systems (AXTA) announced Monday that it has entered into a definitive agreement to acquire The CoverFlexx Group from Transtar Holding Co. for initial cash consideration of $285 million, plus an additional $10 million earnout based on the business' 2024 performance.
RTTNews
|
4h 25min ago
Bay Street Likely To Open On Mixed Note
Canadian shares are likely to open on a mixed note Monday morning, with investors tracking earnings updates and commodity markets for direction. The mood is likely to remain cautious ahead of U.S. inflation data and Fed Chair Jerome Powell's speech, due later in the week.
RTTNews
|
4h 29min ago
Merus Says FDA Grants Breakthrough Therapy Designation For Petosemtamab To Treat Head & Neck Cancer
Oncology company Merus N.V. (MRUS) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for petosemtamab for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed following treatment with platinum based chemotherapy and an anti-programmed cell death receptor-1 (PD-1) or anti-programmed death ligand 1 (PD-L1) antibody.
RTTNews
|
4h 29min ago
V2X Appoints Jeremy Wensinger To Succeed Chuck Prow As President And CEO
V2X, Inc. (VVX), a leading provider of global mission solutions, announced Monday that Jeremy Wensinger has been appointed President, Chief Executive Officer and a member of the company's Board of Directors, effective as of June 17, 2024. Wensinger is succeeding Chuck Prow.
RTTNews
|
4h 43min ago
Permira To Take Squarespace Private In $6.9 Bln All-cash Deal
Design-driven platform Squarespace, Inc. (SQSP) announced Monday that it has entered into a definitive agreement to go private by private equity firm Permira in an all-cash transaction valued at approximately $6.9 billion.
RTTNews
|
5h 36min ago
Sensex, Nifty End Modestly Higher After Volatility
Indian shares ended modestly higher on Monday, after having fallen deep into the red earlier in the session due to uncertainty surrounding the general election results.
RTTNews
|
6h 36min ago
European Shares Struggle For Direction In Lackluster Trade
European stocks struggled for direction on Monday after recent string of gains.
RTTNews
|
7h 38min ago
